logo

Catalent Inc. (CTLT)



Trade CTLT now with
  Date
  Headline
2/21/2018 3:17:05 AM Biohaven Says License With Catalent For Zydis Orally Dissolving Tablet With Small Molecule CGRP Receptor Antagonists
2/20/2018 7:50:05 AM Catalent Adds Three New Members To Its Board; Board Member James Quella Retires
2/5/2018 7:53:03 AM Catalent Q2 Loss Per Share $0.16 Vs EPS $0.14 Prior Year
12/13/2017 6:31:51 AM RBC Capital Markets Starts Catalent Inc. (CTLT) At Outperform With $46 Price Target
11/6/2017 7:34:26 AM Catalent Q1 Net Earnings $3.8 Mln Or $0.03/shr Vs. $4.6 Mln Or $0.04/shr Last Year
10/24/2017 2:36:29 AM Cook Group Completes Sale Of Cook Pharmica To Catalent
10/16/2017 7:07:02 AM Catalent Reports Pricing Of Private Offering Of Senior Unsecured Notes Due 2026
10/10/2017 7:10:06 AM Catalent Intends To Offer $450 Mln Of Senior Unsecured Notes Due 2026
9/26/2017 8:51:47 PM Catalent Prices Offering Of 6.40 Mln Shares At $39.10/shr
9/19/2017 7:33:29 AM Catalent To Buy Cook Pharmica For $950 Mln
8/29/2017 9:41:03 AM William Blair Reiterates Catalent Inc. (CTLT) At Ourperform
8/28/2017 4:19:38 PM Catalent Q4 EPS $0.49 Vs. $0.46 Year Ago
5/5/2017 7:39:41 AM William Blair Raises Catalent Inc. (CTLT) To Outperform From Market Perform
12/2/2016 7:59:16 AM Catalent Prices Private Offering Of EUR 380.0 Mln Of 4.75% Senior Unsecured Notes Due 2024